The role of infectious agents in the pathogenesis of vasculitis

Best Practice and Research: Clinical Rheumatology

Volumn 22, Issue 5, 2008, Pages 897-911

  Pipitone, Nicolò ^a   Salvarani, Carlo ^a  

^a Arcispedale Santa Maria Nuova ^*  (Italy)

Author keywords

animal models; cryoglobulinemic vasculitis; hepatitis B virus; hepatitis C virus; human immunodeficiency virus; infection; polyarteritis nodosa; vasculitis

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; HEPATITIS B VACCINE; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE; RIBAVIRIN; RITUXIMAB;

ARTERIVIRUS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL FEATURE; CRYOGLOBULINEMIA; CYTOMEGALOVIRUS; DISEASE MODEL; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HERPES SIMPLEX VIRUS; HOST SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION; LOW DRUG DOSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PLASMAPHERESIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; REVIEW; RICKETTSIA; SYPHILIS; TRANSGENIC MOUSE; VASCULAR DISEASE; VASCULITIS;

ANIMALS; BACTERIAL INFECTIONS; DISEASE MODELS, ANIMAL; HUMANS; VASCULITIS; VIRUS DISEASES;

EID: 56349141062     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2008.09.009     Document Type: Review

References (93)

1. Scott D.G., and Watts R.A. Classification and epidemiology of systemic vasculitis. British Journal of Rheumatology 33 (1994) 897-899
2. Mohan N., and Kerr G. Infectious etiology of vasculitis: diagnosis and management. Current Rheumatology Reports 5 (2003) 136-141
3. Oldstone M.B. Molecular mimicry and immune-mediated diseases. The FASEB Journal 12 (1998) 1255-1265
4. Rodriguez-Pla A., and Stone J.H. Vasculitis and systemic infections. Current Opinion in Rheumatology 18 (2006) 39-47
5. Dal Canto A.J., and Virgin H.W. Animal models of infection-mediated vasculitis. Current Opinion in Rheumatology 11 (1999) 17-23
6. Fong I.W., Chiu B., Viira E., et al. Rabbit model for Chlamydia pneumoniae infection. Journal of Clinical Microbiology 35 (1997) 48-52
7. Esteban M.J., Font C., Hernandez-Rodriguez J., et al. Small-vessel vasculitis surrounding a spared temporal artery: clinical and pathological findings in a series of twenty-eight patients. Arthritis and Rheumatism 44 (2001) 1387-1395
8. Thibault S., Drolet R., Germain M.C., et al. Cutaneous and systemic necrotizing vasculitis in swine. Veterinary Pathology 35 (1998) 108-116
9. Dangler C.A., Baker S.E., Kariuki N.M., and Chia S.H. Murine cytomegalovirus-associated arteritis. Veterinary Pathology 32 (1995) 127-133
10. Berencsi K., Endresz V., Klurfeld D., et al. Early atherosclerotic plaques in the aorta following cytomegalovirus infection of mice. Cell Adhesion and Communication 5 (1998) 39-47
11. Persoons M.C., Stals F.S., dam Mieras M.C., and Bruggeman C.A. Multiple organ involvement during experimental cytomegalovirus infection is associated with disseminated vascular pathology. The Journal of Pathology 184 (1998) 103-109
12. Golden M.P., Hammer S.M., Wanke C.A., and Albrecht M.A. Cytomegalovirus vasculitis. Case reports and review of the literature. Medicine 73 (1994) 246-255
13. Presti R.M., Pollock J.L., Dal Canto A.J., et al. Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. The Journal of Experimental Medicine 188 (1998) 577-588
14. Weck K.E., Dal Canto A.J., Gould J.D., et al. Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease. Nature Medicine 3 (1997) 1346-1353
15. Nicklin M.J., Hughes D.E., Barton J.L., et al. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. The Journal of Experimental Medicine 191 (2000) 303-312
16. Sohn S., Lee E.S., Bang D., and Lee S. Behcet's disease-like symptoms induced by the Herpes simplex virus in ICR mice. European Journal of Dermatology 8 (1998) 21-23
17. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet 335 (1990) 1078-1080
18. Tinkle B.T., Ngo L., Luciw P.A., et al. Human immunodeficiency virus-associated vasculopathy in transgenic mice. Journal of Virology 71 (1997) 4809-4814
19. Terada L.S., Gu Y., and Flores S.C. AIDS vasculopathy. The American Journal of the Medical Sciences 320 (2000) 379-387
20. Gherardi R., Belec L., Mhiri C., et al. The spectrum of vasculitis in human immunodeficiency virus-infected patients. A clinicopathologic evaluation. Arthritis and Rheumatism 36 (1993) 1164-1174
21. Malavolta L.C., and Bechara M.J. Infectious arteritis. Problems in General Surgery 18 (2001) 88-91
22. Frank M.W., Mehlman D.J., Tsai F., et al. Syphilitic aortitis. Circulation 100 (1999) 1582-1583
23. Pagnoux C., Cohen P., and Guillevin L. Vasculitides secondary to infections. Clinical and Experimental Rheumatology 24 (2006) S71-S81
24. Tavora F., and Burke A. Review of isolated ascending aortitis: differential diagnosis, including syphilitic, Takayasu's and giant cell aortitis. Pathology 38 (2006) 302-308
25. Yokoi M., and Kase M. Retinal vasculitis due to secondary syphilis. Japanese Journal of Ophthalmology 48 (2004) 65-67
26. Gaa J., Weidauer S., Sitzer M., et al. Cerebral vasculitis due to Treponema pallidum infection: MRI and MRA findings. European Radiology 14 (2004) 746-747
27. Gajaraj A., and Victor S. Tuberculous aortoarteritis. Clinical Radiology 32 (1981) 461-466
28. O'Regan A.W., Castro C., Lukehart S.A., et al. Barking up the wrong tree? Use of polymerase chain reaction to diagnose syphilitic aortitis. Thorax 57 (2002) 917-918
29. Bacourt F., Goeau-Brissonniere O., Lacombe P., et al. Surgical treatment of a tuberculous thoracoabdominal aneurysm. Annals of Vascular Surgery 1 (1986) 378-381
30. Shah S.M., Howard R.S., Sarkies N.J., and Graham E.M. Tuberculosis presenting as retinal vasculitis. Journal of the Royal Society of Medicine 81 (1988) 232-233
31. Mahr A., Guillevin L., Poissonnet M., and Ayme S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis and Rheumatism 51 (2004) 92-99
32. Guillevin L., Lhote F., Cohen P., et al. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine 74 (1995) 238-253
33. Naouri M., Bacq Y., Machet M.C., et al. Interferon-alpha and ribavirin treatment in a patient with hepatitis C virus-associated cutaneous periarteritis nodosa. Annales de Dermatologie et de Vénéréologie 133 (2006) 679-682
34. Lormeau C., Falgarone G., Roulot D., and Boissier M.C. Rheumatologic manifestations of chronic hepatitis C infection. Joint Bone Spine 73 (2006) 633-638
35. Cacoub P., Renou C., Rosenthal E., et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine 79 (2000) 47-56
36. Lamprecht P., Gause A., and Gross W.L. Cryoglobulinemic vasculitis. Arthritis and Rheumatism 42 (1999) 2507-2516
37. Roccatello D., Baldovino S., Rossi D., et al. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. Nephrology, Dialysis, Transplantation 19 (2004) 3054-3061
38. Chetty R. Vasculitides associated with HIV infection. Journal of Clinical Pathology 54 (2001) 275-278
39. Kaye B.R. Rheumatologic manifestations of HIV infections. Clinical Reviews in Allergy & Immunology 14 (1996) 385-416
40. Font C., Miro O., Pedrol E., et al. Polyarteritis nodosa in human immunodeficiency virus infection: report of four cases and review of the literature. British Journal of Rheumatology 35 (1996) 796-799
41. Massari M., Salvarani C., Portioli I., et al. Polyarteritis nodosa and HIV infection: no evidence of a direct pathogenic role of HIV. Infection 24 (1996) 159-161
42. Chetty R., Batitang S., and Nair R. Large artery vasculopathy in HIV-positive patients: another vasculitic enigma. Human Pathology 31 (2000) 374-379
43. Roh S.S., and Gertner E. Digital necrosis in acquired immune deficiency syndrome vasculopathy treated with recombinant tissue plasminogen activator. The Journal of Rheumatology 24 (1997) 2258-2261
44. Calabrese L.H., Estes M., Yen-Lieberman B., et al. Systemic vasculitis in association with human immunodeficiency virus infection. Arthritis and Rheumatism 32 (1989) 569-576
45. Garcia-Garcia J.A., Macias J., Castellanos V., et al. Necrotizing granulomatous vasculitis in advanced HIV infection. The Journal of Infection 47 (2003) 333-335
46. Gillams A.R., Allen E., Hrieb K., et al. Cerebral infarction in patients with AIDS. AJNR. American Journal of Neuroradiology 18 (1997) 1581-1585
47. Calabrese L.H., Kirchner E., and Shrestha R. Rheumatic complications of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: emergence of a new syndrome of immune reconstitution and changing patterns of disease. Seminars in Arthritis and Rheumatism 35 (2005) 166-174
48. Reveille J.D., and Williams F.M. Infection and musculoskeletal conditions: Rheumatologic complications of HIV infection. Best Practice & Research. Clinical Rheumatology 20 (2006) 1159-1179
49. Massabki P.S., Accetturi C., Nishie I.A., et al. Clinical implications of autoantibodies in HIV infection. AIDS (London, England) 11 (1997) 1845-1850
50. Klaassen R.J., Goldschmeding R., Dolman K.M., et al. Anti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection. Clinical and Experimental Immunology 87 (1992) 24-30
51. Gisselbrecht M., Cohen P., Lortholary O., et al. Human immunodeficiency virus-related vasculitis. Clinical presentation of and therapeutic approach to eight cases. Annales de Médecine Interne 149 (1998) 398-405
52. Salvarani C., Gabriel S.E., O'Fallon W.M., and Hunder G.G. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Annals of Internal Medicine 123 (1995) 192-194
53. Ma-Krupa W., Jeon M.S., Spoerl S., et al. Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. The Journal of Experimental Medicine 199 (2004) 173-183
54. Rimenti G., Blasi F., Cosentini R., et al. Temporal arteritis associated with Chlamydia pneumoniae DNA detected in an artery specimen. The Journal of Rheumatology 27 (2000) 2718-2720
55. Wagner A.D., Gerard H.C., Fresemann T., et al. Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells. Arthritis and Rheumatism 43 (2000) 1543-1551
56. Regan M.J., Wood B.J., Hsieh Y.H., et al. Temporal arteritis and Chlamydia pneumoniae: failure to detect the organism by polymerase chain reaction in ninety cases and ninety controls. Arthritis and Rheumatism 46 (2002) 1056-1060
57. Helweg-Larsen J., Tarp B., Obel N., and Baslund B. No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis. Rheumatology (Oxford, England) 41 (2002) 445-449
58. Mitchell B.M., and Font R.L. Detection of varicella zoster virus DNA in some patients with giant cell arteritis. Investigative Ophthalmology & Visual Science 42 (2001) 2572-2577
59. Rodriguez-Pla A., Bosch-Gil J.A., Echevarria-Mayo J.E., et al. No detection of parvovirus B19 or herpesvirus DNA in giant cell arteritis. Journal of Clinical Virology 31 (2004) 11-15
60. Staud R., and Corman L.C. Association of parvovirus B19 infection with giant cell arteritis. Clinical Infectious Diseases 22 (1996) 1123
61. Gabriel S.E., Espy M., Erdman D.D., et al. The role of parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluation. Arthritis and Rheumatism 42 (1999) 1255-1258
62. Salvarani C., Farnetti E., Casali B., et al. Detection of parvovirus B19 DNA by polymerase chain reaction in giant cell arteritis: a case-control study. Arthritis and Rheumatism 46 (2002) 3099-3101
63. Aggarwal A., Chag M., Sinha N., and Naik S. Takayasu's arteritis: role of Mycobacterium tuberculosis and its 65 kDa heat shock protein. International Journal of Cardiology 55 (1996) 49-55
64. Popa E.R., Stegeman C.A., Kallenberg C.G., and Tervaert J.W. Staphylococcus aureus and Wegener's granulomatosis. Arthritis Research 4 (2002) 77-79
65. Stegeman C.A., Tervaert J.W., de Jong P.E., and Kallenberg C.G. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. The New England Journal of Medicine 335 (1996) 16-20
66. Esper F., Shapiro E.D., Weibel C., et al. Association between a novel human coronavirus and Kawasaki disease. The Journal of Infectious Diseases 191 (2005) 499-502
67. Cacoub P., Saadoun D., Limal N., et al. Hepatitis C virus infection and mixed cryoglobulinaemia vasculitis: a review of neurological complications. AIDS (London, England) 19 Suppl. 3 (2005) S128-S134
68. Bilge I., Sadikoglu B., Emre S., et al. Central nervous system vasculitis secondary to parvovirus B19 infection in a pediatric renal transplant patient. Pediatric Nephrology (Berlin, Germany) 20 (2005) 529-533
69. Ovetchkine P., Brugieres P., Seradj A., et al. An 8-y-old boy with acute stroke and radiological signs of cerebral vasculitis after recent Mycoplasma pneumoniae infection. Scandinavian Journal of Infectious Diseases 34 (2002) 307-309
70. Heinrich A., Khaw A.V., Ahrens N., et al. Cerebral vasculitis as the only manifestation of Borrelia burgdorferi infection in a 17-year-old patient with basal ganglia infarction. European Neurology 50 (2003) 109-112
71. Younger D.S. Vasculitis of the nervous system. Current Opinion in Neurology 17 (2004) 317-336
72. Zouboulis C.C., and May T. Pathogenesis of Adamantiades-Behcet's disease. Medical Microbiology and Immunology (Berlin) 192 (2003) 149-155
73. Mizushima Y., Matsuda T., Hoshi K., and Ohno S. Induction of Behcet's disease symptoms after dental treatment and streptococcal antigen skin test. The Journal of Rheumatology 15 (1988) 1029-1030
74. Direskeneli H. Behcet's disease: infectious aetiology, new autoantigens, and HLA-B51. Annals of the Rheumatic Diseases 60 (2001) 996-1002
75. Direskeneli H., and Saruhan-Direskeneli G. The role of heat shock proteins in Behcet's disease. Clinical and Experimental Rheumatology 21 (2003) S44-S48
76. Stanford M., Whittall T., Bergmeier L.A., et al. Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease. Clinical and Experimental Immunology 137 (2004) 201-208
77. Jessop S.J. Cutaneous leucocytoclastic vasculitis: a clinical and aetiological study. British Journal of Rheumatology 34 (1995) 942-945
78. Naides S.J. Known causes of vasculitis in man. Cleveland Clinic Journal of Medicine 69 Suppl. 2 (2002) SII15-SII19
79. Kanai K., Kuwabara S., Mori M., et al. Leukocytoclastic-vasculitic neuropathy associated with chronic Epstein-Barr virus infection. Muscle & Nerve 27 (2003) 113-116
80. Ban S., Goto Y., Kamada K., et al. Systemic granulomatous arteritis associated with Epstein-Barr virus infection. Virchows Archiv 434 (1999) 249-254
81. Murakami K., Ohsawa M., Hu S.X., et al. Large-vessel arteritis associated with chronic active Epstein-Barr virus infection. Arthritis and Rheumatism 41 (1998) 369-373
82. Nakagawa A., Ito M., Iwaki T., et al. Chronic active Epstein-Barr virus infection with giant coronary aneurysms. American Journal of Clinical Pathology 105 (1996) 733-736
83. Dutz J.P., Benoit L., Wang X., et al. Lymphocytic vasculitis in X-linked lymphoproliferative disease. Blood 97 (2001) 95-100
84. Sackier J.M., Kelly S.B., Clarke D., et al. Small bowel haemorrhage due to cytomegalovirus vasculitis. Gut 32 (1991) 1419-1420
85. Meyer M.F., Hellmich B., Kotterba S., and Schatz H. Cytomegalovirus infection in systemic necrotizing vasculitis: causative agent or opportunistic infection?. Rheumatology International 20 (2000) 35-38
86. Merle H., Donnio A., Gonin C., et al. Retinal vasculitis caused by adult T-cell leukemia/lymphoma. Japanese Journal of Ophthalmology 49 (2005) 41-45
87. Marmor M., Hertzmark K., Thomas S.M., et al. Resistance to HIV infection. Journal of Urban Health 83 (2006) 5-17
88. Patti J.M., Allen B.L., McGavin M.J., and Hook M. MSCRAMM-mediated adherence of microorganisms to host tissues. Annual Review of Microbiology 48 (1994) 585-617
89. Patti J.M., Bremell T., Krajewska-Pietrasik D., et al. The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infection and Immunity 62 (1994) 152-161
90. Zhou Y.F., Shou M., Guetta E., et al. Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall. Circulation 100 (1999) 1569-1575
91. Virgin H.W. Immune regulation of viral infection and vice versa. Immunologic Research 32 (2005) 293-315
92. Steed A., Buch T., Waisman A., and Virgin H.W. Gamma interferon blocks gammaherpesvirus reactivation from latency in a cell type-specific manner. Journal of Virology 81 (2007) 6134-6140
93. Hoffman G.S. Large-vessel vasculitis: unresolved issues. Arthritis and Rheumatism 48 (2003) 2406-2414